Return On Equity of Lyra Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lyra Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Lyra Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -1033%, a 478% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2024 was -266%, a 258% decline from 2023.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2023 was -74%, a 1.7% decline from 2022.
  • Lyra Therapeutics, Inc. annual Return On Equity for 2022 was -73%, a 14% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lyra Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1033% -854% -478% 01 Jul 2025 30 Sep 2025
Q2 2025 -412% -268% -187% 01 Apr 2025 30 Jun 2025
Q1 2025 -474% -396% -502% 01 Jan 2025 31 Mar 2025
Q4 2024 -266% -192% -258% 01 Oct 2024 31 Dec 2024
Q3 2024 -179% -104% -138% 01 Jul 2024 30 Sep 2024
Q2 2024 -144% -72% -100% 01 Apr 2024 30 Jun 2024
Q1 2024 -79% -10% -14% 01 Jan 2024 31 Mar 2024
Q4 2023 -74% -1% -1.7% 01 Oct 2023 31 Dec 2023
Q3 2023 -75% +10% +12% 01 Jul 2023 30 Sep 2023
Q2 2023 -72% +25% +26% 01 Apr 2023 30 Jun 2023
Q1 2023 -69% +49% +41% 01 Jan 2023 31 Mar 2023
Q4 2022 -73% +11% +14% 01 Oct 2022 31 Dec 2022
Q3 2022 -85% -25% -42% 01 Jul 2022 30 Sep 2022
Q2 2022 -97% -51% -110% 01 Apr 2022 30 Jun 2022
Q1 2022 -117% -84% -254% 01 Jan 2022 31 Mar 2022
Q4 2021 -84% -8% -9.9% 01 Oct 2021 31 Dec 2021
Q3 2021 -60% -154% -163% 01 Jul 2021 30 Sep 2021
Q2 2021 -46% -70% -287% 01 Apr 2021 30 Jun 2021
Q1 2021 -33% -47% -337% 01 Jan 2021 31 Mar 2021
Q4 2020 -77% -91% -650% 01 Oct 2020 31 Dec 2020
Q3 2020 94% 01 Jul 2020 30 Sep 2020
Q2 2020 25% 01 Apr 2020 30 Jun 2020
Q1 2020 14% 01 Jan 2020 31 Mar 2020
Q4 2019 14% 01 Oct 2019 31 Dec 2019

Lyra Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -266% -192% -258% 01 Jan 2024 31 Dec 2024
2023 -74% -1% -1.7% 01 Jan 2023 31 Dec 2023
2022 -73% +11% +14% 01 Jan 2022 31 Dec 2022
2021 -84% -8% -9.9% 01 Jan 2021 31 Dec 2021
2020 -77% -91% -650% 01 Jan 2020 31 Dec 2020
2019 14% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.